Story · Public Health

Moderna Swings to Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes

1 outlet · first reported by WSJ Health on

The biopharmaceutical company said it now expects total revenue growth of 15% to 25% for the year, compared with a previous outlook for up to 10% growth. (WSJ Health)

Coverage, in order

  1. WSJ Health mainstream
    Moderna Swings to Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes

    The biopharmaceutical company said it now expects total revenue growth of 15% to 25% for the year, compared with a previous outlook for up to 10% growth.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.